PMC:7463108 / 1166-1368
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T13436 | 73-76 | Body_part | denotes | HIV | http://purl.org/sig/ont/fma/fma278683 |
| T69159 | 144-147 | Body_part | denotes | HIV | http://purl.org/sig/ont/fma/fma278683 |
| T39171 | 148-157 | Body_part | denotes | chemokine | http://purl.org/sig/ont/fma/fma241981 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 11 | 116-133 | Gene | denotes | μ-opioid receptor | Gene:4988 |
| 12 | 135-138 | Gene | denotes | MOR | Gene:4988 |
| 15 | 73-78 | Species | denotes | HIV-1 | Tax:11676 |
| 20 | 144-147 | Species | denotes | HIV | Tax:12721 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T8 | 0-202 | Sentence | denotes | These considerations include, understanding the combined consequences of HIV-1 genetic variants, host variants, and μ-opioid receptor (MOR) and HIV chemokine co-receptor interactions on the comorbidity. |